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OVERVIEW 
Historically, the Centers for Disease Control and Prevention’s (CDC’s) National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP) has provided funding for State chronic 
disease programs on a disease-specific level, releasing separate funding opportunity 
announcements (FOAs) to address chronic conditions (e.g., cardiovascular disease, diabetes, 
obesity). However, chronic diseases have a high incidence of comorbidity, and the burden of 
these diseases has continued to escalate. In recognition of these issues, CDC has adopted a more 
integrated approach to chronic disease prevention and control, increasing opportunities for 
coordination across related diseases and 
risk factors so that public health programs 
can work synergistically to be more 
effective and efficient. One recent FOA that 
embraces this approach is the State Public 
Health Actions to Prevent and Control 
Diabetes, Heart Disease, Obesity and 
Associated Risk Factors and Promote 
School Health program (CDC-RFA-DP13-
1305, referred to in this document as 
1305). 
As State health departments are serving on 
the front lines of coordinated chronic 
disease public health prevention efforts, 
grantees are exploring and testing new and 
innovative approaches that will provide 
critical insight and lessons learned. The goal 
of the Emerging Practices in Diabetes series 
is to summarize and share information on 
these practices to inform the work of other 
grantees working in the same or related 
areas. 
In this emerging practice document, we examine the role of pharmacists in chronic disease 
management and highlight examples from three 1305 grantees: Colorado, Iowa, and Ohio. We 
focus specifically on two activities involving the use of pharmacists: medication therapy 
management (MTM) and team-based care. These strategies primarily fall within domains 3 
(health care system interventions) and 4 (community programs linked to clinical services) of the 
four domains for coordinating chronic disease prevention. See Exhibit 1 for the relevant 1305 
strategies and short-term performance measures. 
The Four Domains of Chronic Disease Prevention 
To optimize public health’s efficiency and 
effectiveness, CDC recommends coordinating chronic 





Epidemiology and surveillance to monitor trends 
and track progress 
Environmental approaches to promote health and 
support healthy behaviors 
Health care system interventions to improve the 
effective delivery and use of clinical and other 
high-value preventive services 
Community programs linked to clinical services to 
improve and sustain management of chronic 
conditions 
These four domains help organize and focus the 
effective work the public health community has been 
doing for many years. At the same time, they help 
concentrate efforts to strengthen programs and build 
expertise to address gaps in services. Finally, they help 
government agencies, State and local grantees, and 
diverse public and private partners find new ways to 
work together and support each other’s efforts. 
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Exhibit 1: 1305 Strategies and Short-Term Performance Measures  
Related to Working With Pharmacists 
1305 Strategy Short-Term Performance Measures 
3.2.1: Increase engagement of nonphysician team 
members (i.e., nurses, pharmacists, and patient 
navigators) in hypertension and diabetes management 
in health care systems 
 3.2.01: Proportion of health care systems with 
policies or systems to encourage a multidisciplinary 
team approach to blood pressure control 
 3.2.02: Proportion of health care systems with 
policies or systems to encourage a multidisciplinary 
team approach to A1C control 
 3.2.03: Proportion of patients in health care systems 
that have policies or systems to encourage a 
multidisciplinary team approach to blood pressure 
control 
 3.2.04: Proportion of patients in health care systems 
that have policies or systems to encourage a 
multidisciplinary team approach to A1C control 
4.3.3: Increase engagement of community 
pharmacists in the provision of medication/self-
management for adults with high blood pressure 
and/or diabetes 
 4.3.03: Proportion of community pharmacists that 
promote medication management or self-
management for adults with high blood pressure 
 4.3.04: Proportion of community pharmacists that 
promote medication management or self-
management for adults with diabetes 
Engaging Pharmacists in Diabetes Prevention and Management 
Today, the role of pharmacists is expanding, which gives them greater impact in the changing 
landscape of health care and public health. Beyond dispensing medications, pharmacists also 
provide a range of prevention services to help improve health outcomes. In the United States, 
people with chronic conditions (e.g., diabetes) account for 91% of all prescriptions filled. By 2020, 
it is estimated that 157 million Americans (roughly 49%) will have at least 1 chronic noninfectious 
or infectious medical condition.2 Pharmacists are well positioned to impact this population. By 
understanding the role of pharmacists, public health practitioners can identify opportunities to 
better apply pharmacists’ knowledge and skills to improve the Nation’s health. 
New collaborative care models identify pharmacists as valuable contributors to the health care 
team. Enhanced training equips pharmacists with the necessary skills to provide a variety of 
preventive care and wellness services—thus increasing access to care for patients. Incorporating 
pharmacists in team-based care models increases patient awareness of the importance of 
medication adherence and further encourages and supports behavior change and self-
management of many chronic illnesses and diseases.3 
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 Medication therapy management. The American Pharmacists Association describes MTM as 
a broad range of health care services provided by pharmacists. A consensus definition, 
adopted by the pharmacy profession in 2004, defines MTM as a service or group of services 
that optimize therapeutic outcomes for individual 
patients. MTM goes beyond the medication-dispensing 
role of pharmacists; however, it may take place at the 
same time that medication or a medical device is 
provided. A pharmacist may provide MTM services in all 
care settings (e.g., pharmacies, health care clinics, 
community settings). Pharmacists providing MTM seek to 
ensure that the medication is optimal for the patient and 
his or her health conditions and that the best possible 
outcomes from treatment are achieved.3 Pharmacists use 
MTM to help patients get the best benefits from their 
medications by working with patients to actively manage 
drug therapies and by identifying, preventing, and 
resolving medication-related problems. 
 Team-based care. Pharmacists provide patient care 
services that are compatible and synergistic with the 
patient-centered medical home model and other 
innovative models of team-based care.3 Because they 
often work in the local community, pharmacists extend the health care team from the 
health care setting into the community. Consequently, pharmacists are some of the most 
accessible health care professionals. Research shows real value in pharmacists’ 
management of diabetes and heart disease.3–5 Public health initiatives that promote efforts 
to engage pharmacists as members of the health care team can result in significant 
improvements in the treatment of diabetes, better control of high blood pressure, 
improved management of cholesterol, and reduced overall health care costs.4 







Start by learning about efforts 
being carried out in your State 
and build on them. 
Focus on work that has the 
greatest potential for reach in 
the State. 
Work with pharmacy students 
and assigned adjunct faculty/ 
preceptors. 
Focus on activities or efforts 
that allow you to target people 
with or at risk for 
hypertension/diabetes. 
Avoid funding pilot and/or 
demonstration projects that 
are not founded on scientific 
evidence. 
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COLORADO: TEAM-BASED CARE 
Description 
Program Overview 
Prior to 1305, pharmacist integration in team-based care in Colorado occurred in pockets across 
the State, but there was no statewide coordinated system to strengthen this practice. To address 
this gap, the Colorado Department of Public Health and Environment (CDPHE) is using 1305 funds 
to build a pipeline of experienced pharmacy students to fill roles in community-based sites across 
the State. However, the funds are not used to pay pharmacy students to deliver care. Rather, 
pharmacy students provide Medicaid patients with hypertension and/or diabetes with 
medication adherence support and disease testing and management services. Students conduct 
these activities in partnership with the client’s primary care provider (PCP) to achieve better 
health outcomes. 
CDPHE established strategic partnerships that led to the development of a pilot program, the 
Regional Care Collaborative Pharmacy Integration Project, to integrate pharmacists into care 
coordination efforts. The project supports a regional and holistic approach to care in the 
geographically large State. CDPHE worked closely with its internal epidemiology and data 
departments to use geographic information system (GIS) disparity mapping to identify target 
areas with a shortage of providers and a high prevalence of diabetes and hypertension. CDPHE 
formed partnerships with select Medicaid Accountable Care Organizations, known in Colorado 
as Regional Care Collaborative Organizations (RCCOs), and with pharmacies in those target areas. 
RCCOs span seven regions in Colorado, connecting Medicaid clients to providers and services. 
Because pharmacists are not recognized Medicaid providers in Colorado, partners determined 
that integration of pharmacists at the RCCO level would be a viable solution, with RCCOs 
contracting with pharmacies to provide services. CDPHE initially partnered with an RCCO to 
develop a sustainable model for the inclusion of pharmacists in approaches to care coordination. 
This approach also allowed CDPHE to generate evidence using Medicaid data to encourage other 
RCCOs in the State to adopt or adapt CDPHE’s approach to team-based care. Fourth-year 
pharmacy students from the University of Colorado’s Skaggs School of Pharmacy and 
Pharmaceutical Sciences (Skaggs) and Regis University School of Pharmacy (Regis) were 
integrated into the pilot program to alleviate the financial burden on RCCOs associated with 
pharmacy-based MTM services. 
The following outlines the flow of services for the pilot program: 
 RCCOs enroll Medicaid clients into the pilot program at preferred pharmacies.
o Eligible clients must have hypertension and/or diabetes and demonstrate a history of
nonadherence to medication treatment. RCCOs may also review hospitalization history
to identify eligible patients to invite as clients in the Regional Care Collaborative
Pharmacy Integration Project.
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 Fourth-year pharmacy students from Regis and Skaggs are required to complete rotations at 
preferred sites that are guaranteed student placements each year, providing medication 
adherence and disease management services at no cost to the RCCO or its clients (patients). 
o Prior to placement, Skaggs requires students to participate in training on the electronic 
client data tracking system and a refresher course in motivational interviewing. 
 Students update client information in an electronic client data tracking system that Skaggs 
developed. 
 Students work with CDPHE and the RCCO to track clients who receive services at preferred 
pharmacies. 
 Students share client information with clients’ PCPs and RCCOs. 
 Primary care providers that participate in this program share client data with RCCOs. 
 PCPs use pharmacists’ data to inform clinical decisions. 
 Skaggs collates client attitudinal and clinical data from preferred pharmacies, and the RCCO 
collates clinical data from PCPs and claims data from Medicaid to create a fuller picture 
when assessing changes in health outcomes. 
Exhibit 2 provides a visual depiction of the contributions and roles of pharmacists, fourth-year 
pharmacy students, PCPs, and RCCOs participating in the Regional Care Collaborative Pharmacy 
Integration Project. 
Exhibit 2: Regional Care Collaborative Pharmacy Integration Project, 2014–2016 
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Role of the State Health Department 
CDPHE has played several key roles in the planning, development, and implementation of this 
project: 
 Convener. Since the onset of this work, CDPHE primarily functions as a convener and 
facilitates communication between internal and external partners to ensure processes 
advance with a shared understanding of the purpose and goals of the program and 
collaboration. 
 Funder. CDPHE’s 1305 funding has allowed the State to support several key partner 
activities. The Colorado State Health Department also funds Skaggs’s and Regis’s strategies, 
including the client information system used at the preferred sites and a pharmacy student 
resource book. 
 Evaluator. CDPHE uses project data from the RCCO, Skaggs, and Regis to assess the impact 
of pharmacy integration into team-based care for Medicaid clients within an accountable 
care system to enhance a model that can be implemented across different RCCO regions 
statewide. 
Role of Partners 
For this project, CDPHE built upon existing partnerships with two Colorado-based schools of 
pharmacy (Skaggs and Regis) and two major pharmacy associations (the Colorado Pharmacists 
Society and RX Plus). 
Both pharmacy associations were interested in Medicaid’s pharmacist-related policies and the 
elimination of billing barriers for services provided. CDPHE’s partnership with Skaggs was 
developed prior to 1305 for work with diabetes self-management education in pharmacies. 
CDPHE expanded this partnership to identify ways to perform additional cardiovascular disease 
and hypertension work in pharmacies statewide. Skaggs and Regis were interested in educating 
and developing opportunities for students to practice disease management activities. CDPHE 
brought together the interests of the pharmacy associations, the schools of pharmacy, and the 
State’s overall vision for care in Colorado into the development of a model for integrating 
pharmacists into team-based care. 
CDPHE’s key partners in this effort are highlighted in Exhibit 3. 
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Exhibit 3: Partner Roles and Responsibilities  
Key Partners Roles and Responsibilities 
Regional Care Collaborative 
Organization (RCCO) 
Ensures geographically targeted areas capture Medicaid recipients for the pilot 
program and refers eligible clients to preferred pharmacy sites. The RCCO is 
the liaison between the pharmacy, PCPs, and clients, and is responsible for 
analyzing claims data and enrolling clients in the program. 
University of Colorado’s 
Skaggs School of Pharmacy 
and Pharmaceutical Sciences 
(Skaggs) and Regis University 
School of Pharmacy (Regis)  
Place fourth-year pharmacy students in preferred pharmacy sites. Students 
provide medication adherence and disease testing and management services 
emphasizing diabetes, hypertension, and cardiovascular disease. Students also 
capture client biometric and attitudinal data in the pharmacy database. Skaggs 
developed a resource manual to provide students with guidance on delivering 
medication adherence and disease testing and management services at 
community pharmacies. Topics in the guide include measuring and improving 
adherence, self-monitoring and management, and making lifestyle changes 
including referral to the Colorado Quitline (to assist clients to quit smoking). 
The resource guide is a tangible product of CDPHE’s partnership with Skaggs 
that CDPHE hopes to share with pharmacies outside the pilot program. Skaggs 
is also contracted to develop and maintain the client data tracking system. 
Other Partners Roles and Responsibilities 
Colorado Pharmacists Society 
and Rx Plus  
Provide CDPHE with guidance on Medicaid policies. (The Colorado Pharmacists 
Society has an established relationship with Colorado’s Medicaid office.) 
Provides access to independent pharmacy staff through meetings and an 
annual pharmacist survey. 
CDPHE’s Experience Implementing the Initiative 
Facilitators 
A key facilitator in the implementation of CDPHE’s 1305-related work is mutually beneficial 
partnerships, as discussed above. Other key facilitators include the following: 
 Partners’ approach to this scope of work. Regis’s and Skaggs’s interest in enhancing student 
skills in team-based care is an asset to this work. 
 Support from the State Medicaid office. Because the State Medicaid office is committed to 
achieving coordinated care, it is supportive of the pilot program and remains a partner in 
identifying and addressing current barriers. 
 Internal capacity and resources. Access to internal resources and staff (including the 
epidemiology and data department as well as internal evaluation staff who assisted with 
the development of logic models) is critical. These items were built into the 1305 budget to 
allow for the use of CDPHE staff time. 
 Consistent messaging. Consistent messaging to and through federal entities (e.g., CDC and 
the Health Resources and Services Administration) pushed the work forward, increased its 
visibility, and facilitated conversations with internal and external partners. 
 Access to relevant resources describing team-based care. Availability of outcome data from 
the Asheville Project and similar studies, pharmacy-specific CDC publications and tools, 
 
Colorado: Team-Based Care 
Emerging Practices in Diabetes Prevention and Control: Work With Pharmacists 8 
research and institutional knowledge on pharmacy integration, and Colorado-based service 
delivery models facilitated the planning and direction of this program. 
Challenges 
CDPHE did not experience any critical challenges during the implementation of this initiative. 
Experiences navigating new relationships and limitations are described. 
 Navigating Medicaid reimbursement policies. CDPHE experienced some difficulty when 
navigating Medicaid reimbursement for pharmacy-based services, as Colorado Medicaid 
does not currently recognize pharmacists as a qualified billing provider. Because of this, and 
to promote a coordinated approach to team-based care, the project utilizes RCCOs as the 
care coordinating and contracting entity, which enables them to reimburse pharmacists for 
services rendered. 
 Lack of interoperability of the electronic health records across health care settings. Since this 
is a new system, users are still trying to determine how to best share data across pharmacy 
and primary care practice sites while ensuring that data are useful for different 
practitioners. CDPHE believes 1305 work and increasing communication between health 
care settings will help refine the system. 
 Sustaining promotion of team-based care among competing interests. Ensuring 1305-
related activities remain relevant and a priority among competing interests in quality 
improvement and system change work is critical, given the multiple demands made on 
clinics and providers daily. 
 Provider environment. Clinics do not see just Medicaid clients, but a mix of many publicly 
and privately insured patients. CDPHE has to identify the most appropriate approach for 
these different entities by working to understand the relationships and coverage areas for 
multiple private payers, traditional Medicare and Medicare Advantage payers, traditional 
Medicaid, and RCCOs. This primary remaining challenge is refining the service delivery 
model so that it works for all types of payers and can continue to be a viable way to engage 
pharmacists, even as the pharmacy profession evolves to meet new demands. 
Conclusion 
Next Steps 
Moving forward, CDPHE would like to use data gathered through this pilot program to ensure it 
is actionable at the consumer and provider clinic level. The cycle of defining, testing, refining, and 
disseminating outcomes remains a key building block in the State’s efforts to improve pharmacy-
based medication adherence and testing and disease management services provided to 
Medicaid, Medicare, and privately insured patients. Core outcomes include the development of 
a service delivery model that can be implemented in any RCCO across the State, a description of 
the financial benefit for utilization of pharmacists at the regional care level, and improved 
services and health outcomes for clients with hypertension or diabetes across Colorado. These 
outcomes are aligned with the goals of the Triple Aim,6 which intend to reduce the cost of care, 
improve the patient experience, and improve the health of all Coloradans. 
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A second RCCO has expressed interest in developing a similar model, and CDPHE is currently in 
conversations defining future work. Since each RCCO is local and has its own specifications, 
models being considered for future exploration include 
additional ways to contract with individual pharmacies, hire 
RCCO staff pharmacists, or utilize a third-party to provide 
adherence and medication therapy management services, all of 
which will help achieve sustainability. 
Lessons Learned 
 Take the time needed to assess the landscape. Thoughtfully plan and foster strategic 
partnerships before program implementation. 
 Develop a heterogeneous team of partners that are best suited to do the work. 
 Discuss organizational capacity and needs with partners to promote coordination of 
partners’ efforts. This might require asking partners challenging questions. Be prepared for 
difficult responses. 
 Be flexible and open rather than prescriptive to innovative approaches to care coordination. 
 Stakeholders may have disparate interests and goals. Find common ground among partners, 
and make sure it is reflected in any action plan. 
Resources Suggested by CDPHE 
 CDPHE’s 1305-funded model for pharmacy integration into team-based care 
For More Information 
Tara Trujillo, Community 
Clinical Linkages Coordinator 
tara.trujillo@state.co.us 
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IOWA: TEAM-BASED CARE 
Description 
Program Overview 
The Iowa Department of Public Health (IDPH) has identified ways to establish and sustain 
partnerships between pharmacists and providers through promoting health systems 
interventions that involve team-based care. This includes two interventions: (1) team-based care 
strategies with the University of Iowa’s College of Pharmacy and (2) the Pharmacy Practice 
Advancement Strategy Project in collaboration with the Iowa Pharmacy Association (IPA). 
IDPH’s team-based care strategy targeting hypertension began prior to 1305 funding and 
expanded to include diabetes management and hemoglobin A1C testing during fiscal years 2013–
2015. A CDC project officer encouraged IDPH to foster a partnership with researchers at the 
University of Iowa exploring team-based care strategies as a means to address hypertension. 
After a series of meetings, the University of Iowa’s College of Pharmacy (COP) and IDPH combined 
efforts and defined the direction of the collaboration. 
The following outlines the implementation of IDPH’s 1305-funded team-based care strategies: 
1. The University of Iowa’s COP recruits providers and pharmacists who are interested and 
new to care coordination. 
2. After recruiting interested health professionals, COP meets in person with both the 
provider and the pharmacist (and any additional involved staff) to guide discussions about 
the parameters of the partnership. 
3. COP provides participating health professionals with a booklet and CD of resources and 
guidance materials to facilitate the implementation of care coordination. 
4. Both IDPH and COP encourage the participating provider to refer patients with high blood 
pressure and/or diabetes who are newly diagnosed, lack hypertension control, or have 
high A1C levels to work with the participating pharmacist on a continuous basis between 
visits to the provider. The pharmacist may then provide testing and education and discuss 
compliance issues with the patient and suggest that the provider add, discontinue, or 
modify prescribed medications. 
5. COP monitors the partnership over a 4- to 6-month period and provides technical 
assistance as needed. 
The Pharmacy Practice Advancement Strategy Project emerged from supplemental 1305 funding. 
IDPH selected IPA as its primary partner for this strategy because of the association’s statewide 
presence. IDPH initially formed a relationship with IPA through work on the CDC-funded 
Community Transformation Grant and has since maintained this relationship. Under 1305, IPA 
seeks to promote, foster interest in, and establish team-based care collaborations leading to the 
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development of formal collaborative practice agreements. The State works with IPA to achieve 
these goals through three activities: 
1. Implementing the Pharmacy Engagement Assessment Survey during year 2 of the 1305 
project period to explore pharmacists’ current roles, responsibilities, and educational 
needs. 
2. Supporting the Pharmacy Practice Advancement Strategies Forum using survey results to 
inform the development of a 1-day educational forum. 
3. Supporting regional meetings during which smaller groups of pharmacists are encouraged 
to invite providers to participate in networking and educational opportunities in team-
based care. 
With guidance from the State’s CDC Project Officer, and using other State surveys as a basis for 
development, IDPH worked with IPA to create the Pharmacy Engagement Assessment Survey. 
The survey was disseminated to each pharmacy—chain-based, independent, franchise-based, 
and hospital-based—licensed with the Iowa Pharmacy Board. IPA and the State disseminated a 
total of 711 surveys and achieved a response rate of 30%. 
Role of the State Health Department 
IDPH’s role in the implementation of both the Pharmacy Practice Advancement Strategy Project 
and team-based care strategies is to initiate communication with new partners, develop the 
parameters of the partnerships and any associated contracts, maintain regular correspondence 
with partners and subcontractors, review reports to inform the direction of the program for 
subsequent fiscal years, present findings to stakeholders during forums and other events, and 
collate materials from CDC and the Million Hearts initiative to share with partners to keep 
resources current. IDPH also seeks to explore ways funds can be leveraged to achieve shared 
goals and target shared interests with new partners. 
Role of Partners 
With resources from 1305, IDPH expanded a previously established partnership with IPA and the 
University of Iowa and recruited new partners, as outlined in Exhibit 4 below.  
 
Iowa: Team-Based Care 
Emerging Practices in Diabetes Prevention and Control: Work With Pharmacists 12 
Exhibit 4: Partner Roles and Responsibilities  
Key Partners Roles and Responsibilities 
Iowa Pharmacy Association 
(IPA)  
Serves as a sole-source contract with IPA for the Pharmacy Practice Advancement 
Strategy Project to build relationships with practices through IPA’s statewide 
connections. 
University of Iowa College 
of Pharmacy (COP) 
Contracts with IDPH to recruit health care providers and pharmacists interested in 
a collaborative approach to care provision. 
Other Partners Roles and Responsibilities 
Drake University Subcontracts with IPA and assists with the development of the Pharmacy 
Engagement Assessment Survey and data collection/entry. 
Iowa Hospital Association Refers interested pharmacists and providers to IDPH and invites IDPH to present 
pharmacist-related work at Iowa Hospital Association conferences. 
Iowa Medical Society Provides IDPH with preliminary guidance on organizations to contact. 
IDPH’s Experience Implementing the Initiative 
Facilitators 
A key facilitator in the implementation of IDPH’s 1305-related work is the development of 
mutually beneficial partnerships. Other key facilitators include the following: 
 Partners’ approach to this scope of work. Partners’ enthusiasm about promoting, 
coordinating, and implementing team-based care and their connections (i.e., actual 
pharmacists) outside the network of partners that IDPH has established facilitates program 
implementation. Established partners’ enthusiasm also attracts and facilitates the 
development of new partnerships. 
 CDC and Million Hearts webinars and information describing care coordination and team-
based care. Million Hearts resources are used to guide partnerships under team-based care 
strategies. 
 IDPH’s internal review of relevant research articles. IDPH reviewed University of Iowa 
research articles describing evidence-based and emerging practice strategies in care 
coordination prior to meeting with the research team. Doing the work on the front end was 
important to ensure that the meeting with University of Iowa researchers would be 
productive. 
Challenges 
IDPH experienced some challenges during the implementation of their team-based care 
strategies (highlighted below); however, these experiences did not significantly hinder the 
implementation of these strategies. 
 Low response rate. The survey had a 30% response rate which limits the generalizability of 
the results. 
 Recruiting pharmacists and providers. Although health care professionals expressed interest 
in participating, IDPH found that providers and pharmacists have competing interests and 
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demands on their time, making it difficult to prioritize participation in a team-based care 
collaboration. 
 Navigating the policies and procedures experienced when establishing a 
partnership/contract with an academic institution. Approving contracts and continuation 
proposals with academic institutions can be a lengthy process, which can delay the 
implementation of project activities and impact the program’s timeline. 
 Becoming familiar with requirements of the funding mechanism. Transitioning to a new 
funding modality, receiving funds, and becoming familiar with the funding mechanism’s 
performance measures require an investment of staff time. 
 Enhancing the appeal of care coordination. Legislation in Iowa does not permit pharmacists 
to be reimbursed for their team-based care efforts.  This restriction can limit pharmacists’ 
enthusiasm to participate. IDPH and their partners are working on strategies to address 
reimbursement policies to enhance the appeal of team-based care for pharmacists. 
Conclusion 
Next Steps 
IDPH plans to evaluate the success of its team-building strategies as well as the current status of 
pharmacist-provider collaborations established with 1305 funding to identify successful 
approaches to building team-based care collaborations. IDPH also plans to use survey results to 
create tailored Pharmacy Practice Advancement Strategies Forum breakout sessions. 
Lessons Learned 
IDPH offered the following lessons learned and recommendations for public health practitioners 
who are considering similar efforts: 
 Obtain support from your State pharmacy association during the initial stages of your 
efforts. 
 Instead of starting from scratch, use resources available through educational institutions. 
These institutions may have established relationships within the targeted community. 
 Avoid launching multiple new efforts at the same time. Each new effort has its own learning 
curve and issues to navigate. 
 After reviewing all available data sources, you may need additional information to help 
inform the project’s scope of work. Consider modifying an existing survey or developing a 
new survey to collect the necessary data. To promote a high response rate, offer different 
modes of access (e.g., online and paper-based formats) along with reminder processes. Be 
sure to minimize burden on potential partners to the extent possible. 
Resources Suggested by IDPH 
 Iowa’s Million Hearts Initiative 
 Fostering Provider-Pharmacist Team Management of 
Hypertension in the Community
For More Information 
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OHIO: MEDICATION THERAPY MANAGEMENT 
Description 
Program Overview 
Through its 1305 funding, the Ohio Department of Health (ODH) has engaged three federally 
qualified health centers (FQHCs) in a pilot project to measure the impact of MTM services on 
chronic disease. In this effort, ODH is seeks to reach patients with uncontrolled blood pressure 
and hemoglobin A1c using sustainable MTM service models. The primary aims of the project are 
to decrease the number of patients with poorly controlled hemoglobin A1C (A1C > 9%) and poorly 
controlled blood pressure in control (defined as >140/90 mmHg). The project also seeks to 
identify adverse drug events (or potential adverse drug events) and to promote diabetes 
composite control (defined as A1C, blood pressure, and LDL in control). 
Role of the State Health Department 
ODH has played several key roles in the planning, development, and implementation of this 
project: 
 Convener and connector for the overall project. From the onset of this work, ODH’s primary 
role has been to serve as the convener and connector across all partners and aspects of the 
project. ODH played an integral part in identifying and assembling key relevant partners 
who have helped to plan and launch the current effort. ODH has access to local health 
departments and projects in counties throughout the State in which they would like to add 
sites. 
 Funder. While funder is an obvious and intuitive part of ODH’s role, 1305 funding has 
allowed ODH to support a portion of the time and activity contributed toward this work by 
its partners. ODH acknowledges that many partners are doing more work than they are 
being funded to do. This limited funding, however, has helped show partners that their 
work is recognized, supported, and valued. 
 Consensus facilitator. ODH was instrumental in helping the overall project team come to 
consensus on project outcomes. Within the project, there were many potential outcomes 
related to chronic disease and medication management. ODH helped the team prioritize 
outcomes they believed to be most important, yet still tied to 1305 priorities. 
 Evaluator and disseminator of information. ODH has taken the lead in ensuring that 
outcomes are being evaluated as the work progresses and that the project team is making 
decisions based on data and the impact of the work. ODH collects, analyzes, reports, and 
disseminates information in a way that is usable and actionable by partners and presentable 
and understandable to relevant audiences. 
Role of Partners 
In developing this program, ODH initiated a new relationship with the Ohio State University 
College of Pharmacy and expanded previously established partnerships with several other 
entities, as outlined in Exhibit 5. 
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Exhibit 5: Partner Roles and Responsibilities  
Partners Roles and Responsibilities 
The Ohio State University College 
of Pharmacy  
Supports project planning and development. Also provides ODH with 
knowledge of and expertise in MTM and FQHCs through access to 
pharmacy faculty and residents and linkages to pharmacy practitioners 
and practice sites across the State. 
Ohio Pharmacists Association 
(OPA) 
Supports project planning and development. Provides access to the 
statewide pharmacy network and expertise in communicating with 
pharmacists, insurers, and payers statewide. 
Ohio Association of Community 
Health Centers (OACHC) 
Three pilot sites: 
 AxessPointe 
 Primary One Health 
 Health Partners of Western Ohio 
 Athens/Southeast Ohio 
Involved in project planning and development. Serves as a touchpoint for 
all FQHCs in the State, providing an avenue for ODH to reach FQHCs. 
Allows ODH and its partners to give presentations on the MTM work at 
their annual meetings and created a web page with resources for all the 
MTM work conducted in Ohio. 
The three pilot sites are affiliated with OACHC. It identifies and recruits 
patients into the program and collects and reports data.  
Health Services Advisory Group  Health Services Advisory Group is Ohio’s Medicare quality innovation 
network/quality improvement organization. Health Services Serves as an 
essential partner from the onset of the project. Shares resources from 
previous medication adherence projects. Regularly attends meetings and 
provides a data collection tool that was adapted for use by FQHCs. 
ODH’s Experience Implementing the Initiative 
Facilitators 
Numerous factors have helped facilitate Ohio’s work across this program, as outlined below: 
 Involving the “right people” from the “right places” in the initiative. Across partners, the 
individuals involved in this initiative are engaged in, and passionate about, the work. 
 Taking time up front to thoughtfully plan the initiative. Together with its partners, ODH 
spent approximately five months meeting and thinking about the needs in the state, the 
goals of the project, and ways to best operationalize and build on this work. Taking this time 
to talk, bring in different partners, and hear different perspectives, allowed the team to 
thoughtfully conceptualize and successfully implement their plan. 
 Maintaining close and frequent communication across all partners. From the beginning of 
the planning process, individuals involved in this work met and spoke regularly to share 
ideas and build on successes achieved. 
 Implementing the pilot in one type of pharmacy setting (not mixing pharmacy sites in 
FQHCs, retail chains, etc.). Working within one pharmacy setting allowed for the planning 
team to focus on one type of model and for challenges to be addressed and resolved more 
easily. 
 Giving participating FQHC sites the flexibility to recruit patients using approaches of their 
choosing. ODH and its partners intended for this to be a “real world” project in that MTM 
was conducted at the individual FQHCs in the way they typically would. FQHCs were 
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expected to implemented new and different approaches to recruitment but rather allowed 
to continue recruiting as they traditionally would. 
 Allowing participating FQHC sites to develop their own protocols for patient enrollment in 
MTM. Each of the participating FQHCs developed their own protocols for enrolling patients 
into MTM which allowed them to stay true to the culture of their site. 
 Using or adapting model data collection tools previously developed by the Alliance for 
Integrated Medication Management. Not having to develop data collection instruments 
from scratch allowed for time and energy to be spent on other areas of the initiative. 
 Selecting data points that align with what the pharmacy sites were already doing. This 
helped to minimize data collection/extraction burden among the FQHCs. 
 Enlisting an academic partner to take the lead on information/data dissemination. Given 
that publication and dissemination are a large part of the culture in academia, having a 
partner on board with the expertise and comfort in playing this role has been a great 
benefit in promoting the work that has been done through this initiative. 
Challenges 
Ohio has experienced few challenges to date in this work, including the following: 
 Finding providers to champion the MTM model. It takes time to identify providers on the 
team who are willing to speak to patients about the importance of medication therapy 
management and the importance of seeing the pharmacist for this type of review and care. 
 Building knowledge and awareness of the value of the MTM model. Ohio is focused on 
sharing data and outcomes from this initiative to address this issue. 
 Establishing a fourth site in rural Appalachian Ohio. Ohio is looking to expand this work into 
a community pharmacy setting; identifying practices that are currently doing this work has 
been a challenge. 
Conclusion 
Early Successes 
ODH’s initial steps accomplished in year 1 include the following: 
 Formed an MTM consortium of leaders from the seven Ohio colleges of pharmacy 
 Developed and implemented contracts with key partners that included data-sharing plans 
 Developed a website to manage and coordinate project efforts across sites and to share 
resources 
 Developed a data collection tool for tracking clinical outcomes and gathering data for 
performance measurement 
By the Numbers 
 Just over 44.8% of those patients who initially had hemoglobin A1c levels greater than 9% 
had had a controlled hemoglobin A1c measurement at 6 months into the program.a 
                                                     
a The program defines hemoglobin A1c “in control” as a hemoglobin A1C measurement less than or equal to 9%. 
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 Nearly 68.6% of patients with blood pressure greater than or equal to 140/90, initially, had 
blood pressure measurement defined as “in control” at six months into the program.b 
Next Steps 
Next steps in this work include expanding the model to additional FQHCs and engaging two 
additional Ohio colleges of pharmacy to implement MTM with primary care practices and 
independent pharmacies that serve 340b clients. 
Lessons Learned 
Lessons learned from ODH’s work on this project are as follows: 
 Collect data more frequently than usual (i.e., more than once annually). 
 Start with the right partners (e.g., the State pharmacy association and the college of 
pharmacy at a larger university). 
 Take the time needed to thoughtfully plan the work before launching the effort. 
Resources Suggested by ODH 
 CDC’s A Program Guide For Public Health: Partnering with Pharmacists in the Prevention 
and Control of Chronic Diseases 
 Poster presentation: MTM in FQHCS: Improving Chronic Disease Outcomes 
 The Patient Safety and Clinical Pharmacy Services Collaborative’s 2012 National 
Performance Story
                                                     
b The program defines hypertension “in control” as a blood pressure measurement of less than 140/90. 
For More Information 
Barbara Pryor, Manager, Chronic 
Disease Section 
Barbara.pryor@odh.ohio.gov 
Jen Rodis, Assistant Dean for Outreach 
and Engagement, Ohio State University 
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